Oncotelic Therapeutics Inc (OTC:OTLC) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bobby W Phd Sandage Other companies: Fortress Biotech, Inc. (President, Director · Sep 13, 2011 – Apr 5, 2013 · Past); Indevus Pharmaceuticals Inc (Executive Vice President · Jan 25, 2006 – Feb 23, 2009 · Past) | Director · Oct 25, 2016 – Jun 20, 2018 · Past |
| Gerald PhD McMahon Other companies: Harpoon Therapeutics Inc (President and CEO, Director · Feb 7, 2019 – Jan 28, 2021 · Past); Celldex Therapeutics, Inc. (Director · Dec 14, 2016 – Dec 3, 2018 · Past) | Director · Sep 2, 2011 – Jun 1, 2016 · Past |
| Amit Shah | CFO · Since at least Nov 5, 2026 |
| Anthony E. Maida | Chief Clinical Officer-Translational Medicine · Since at least Nov 5, 2026 |
| Chulho Park | CHIEF TECHNOLOGY OFFICER · Apr 22, 2019 – Nov 19, 2020 · Past |
| Donald Rogers Reynolds | Director · Oct 25, 2016 – Jun 20, 2018 · Past |
| Matthew M Loar | Chief Financial Officer · Jul 20, 2015 – Jun 20, 2018 · Past |
| Pamela Ha | Controller · Jun 4, 2015 – Jun 4, 2015 · Past |
| Saran Saund | CBO · Since at least Mar 31, 2021 |
| Seymour Howard Fein | CRO/CMO · Since at least Jul 10, 2026 |
| Steven W. King | Inc. · Until Oct 30, 2026 · Past |
| Vuong Trieu | CEO/Chairman of Oncotelic Inc. · Since at least Jul 8, 2025 |
| William D Schwieterman | President and CEO, Director · Mar 21, 2016 – Jun 20, 2018 · Past |